SightGlass Vision, Inc.
This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
Juvenile Myopia
Myopia
Novel spectacle lens design
NA
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 175 participants |
Masking : | SINGLE |
Masking Description : | Evaluator/Investigational site staff tasked with measuring key primary variables (i.e., axial length and SER) will be masked to participant's former treatment group. |
Primary Purpose : | TREATMENT |
Official Title : | Clinical Assessment of DOT Spectacle Lenses in Chinese Children Extension |
Actual Study Start Date : | 2025-06-30 |
Estimated Primary Completion Date : | 2026-09-30 |
Estimated Study Completion Date : | 2026-12-31 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 8 Years to 16 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Aier Eye Hospital
Changsha, China,
RECRUITING
West China Hospital
Chengdu, China,
NOT YET RECRUITING
Zhongshan Ophthalmic Center
Guangzhou, China,
RECRUITING
Fudan university one
Shanghai, China,
RECRUITING
Tianjin Eye Hospital
Tianjin, China,